Keynows

2

Unit 3 Group 1 Assignment

Company and Product Background

Johnson & Johnson (J&J) is a multinational company based in the United States of America. The company has its headquarters in New Brunswick, New Jersey, U.S. J&J was formed in 1886 January by Robert Wood Johnson 1, Edward Mead Johnson and James Wood Johnson. Their names defined the name of the company. J&J operates in the Pharmaceutical, medical devices and consumer healthcare industry. The company has over 250 subsidiary companies, with operations in over 60 countries. The company's essential products include; baby products, bandages, Tylenol medications, Acuvue contact lenses, facial wash, and a wide variety of medical equipment supplies. The products are consumed in over 175 countries internationally (Johnson & Johnson, 2021).

The company has shown high commitment in the past and at present in fighting against diabetes, especially in the developing countries; Guyana, Nepal, Zimbabwe, Sri Lanka, Guatemala and Mali. It has partnered with the International Diabetes Federation (IDF), managing diabetes in over 160 countries globally since the 1950s. J&J has formed the Johnson & Johnson Family of Diabetes, consisting of five of its subsidiary companies. The five companies include; LifeScan, Inc., Animas Corporation, Calibra Medical, and the Johnson & Johnson Diabetes Institute, LLC. The Animas Corporation is involved in developing innovative insulin systems, which matches the product requirements in question. J&J's primary objectives have been on promoting diabetes care globally, prevention and cure. The company has supported The Life for a Child program financially and through medical supplies. Currently, Johnson & Johnson serves as the most significant donor to the diabetes program, wiring millions and millions of monies on every diabetes day, 14th November (Boccardi et al., 2019). 

Diabetes has become a crucial health issue in the United States. Annually, young Americans aged below 20 years, amounting to 5,089, are diagnosed with this metabolic condition. One in every 10 Americans has diabetes, suggesting that over 34.2 million Americans struggle with this disease. Key contributing factors have been identified as obesity, exposure to endocrine-disrupting chemicals, among others. Diabetes has serious health effects, such as the possibility of developing blindness, kidney failure, increased chances of developing Alzheimer's disease, heart disease, nerve damage, and eventual death. Factoring out the adverse health effects of this disease, there has been an increasing need to develop proper prevention and treatment approaches. The focus has mainly been on developing products that can manage the disease and keep the blood sugar within the appropriate levels, to eliminate metabolism imbalances.

There have been numerous advancements in technology aiming at improving the treatment and management of diabetes. The product under consideration was recently approved by the Food and Drug Administration (FDA). The product is a significant advancement in this field, considering that glucose meter, insulin pump, and dose calculator have all been integrated into one device. Such integration enhances the product's usage convenience and leads to better health outcomes in the management of diabetes. Several American Corporations have been involved in the manufacture and distribution of this product. The product is expected to be used in healthcare facilities such as hospitals, nursing homes, doctor's offices, rehabilitation centres, centres for collecting blood and plasma, medical and clinical research laboratories, and by patients at their homes, following the usage of the prescriptions issued by their healthcare professionals. Johnson & Johnson (J&J) has been on the frontline in the fight against diabetes, and therefore, it will be the most appropriate company to be considered in the production of this product.

References

Boccardi, V., Murasecco, I., & Mecocci, P. (2019). Diabetes drugs in the fight against Alzheimer's disease. Ageing research reviews, 54, 100936.

Johnson & Johnson. (2021). Website. Accessed on 17th June, 2021 from https://www.jnj.com/